Gerencia de Atención Integrada de Almansa
-
Purchaser
-
Publication date
Jan 23, 2019
-
Type
Negotiated without publicity
-
Source
-
NOVARTIS FARMACÉUTICA S.A.
Jan 22, 2019
726.8k €
-
GLAXOSMITHKLINE, S.A.
Jan 22, 2019
73k €
-
PFIZER, S.L.U.
Jan 22, 2019
243.2k €
-
ROCHE FARMA, S.A.
Jan 22, 2019
602.5k €
-
AMGEN, S.A.
Jan 22, 2019
88.5k €
-
BAYER HISPANIA, S.L.
Jan 22, 2019
141.3k €
-
JANSSEN CILAG, S.A.
Jan 22, 2019
1.3m €
-
GILEAD SCIENCES, S.L.
Jan 22, 2019
63.1k €
-
UCB PHARMA, S.A.
Jan 22, 2019
244.5k €
-
CELGENE S.L.
Jan 22, 2019
1m €
-
MERCK SHARP & DOHME ESPAÑA, S.A.
Jan 22, 2019
215.9k €
-
BIOGEN SPAIN, S.L.U.
Jan 22, 2019
104.9k €
-
BRISTOL MYERS SQUIBB, S.A.
Jan 22, 2019
356.4k €
-
ASTRAZENECA FARMACEUTICA SPAIN, S.A.
Jan 22, 2019
90.8k €
-
PIERRE FABRE IBERICA, S.A.
Jan 22, 2019
83.6k €
-
VIFOR PHARMA ESPAÑA, S.L.U.
Jan 22, 2019
27.4k €
-
TAKEDA FARMACEUTICA ESPAÑA SA
Jan 22, 2019
76.4k €
-
EISAI FARMACEUTICA,S.A.
Jan 22, 2019
38.5k €
-
LILLY, S.A
Jan 22, 2019
158.1k €
-
SHIRE PHARMACEUTICALS IBERICA, SL
Jan 22, 2019
422.5k €
Awards
-
Notices
-
Jan 23, 2019
Anuncio de Adjudicación
-
Feb 25, 2019
Anuncio de Formalización
-